Aug 31
Press Release
30 August 2010, Wexham: ?Procoralan® (ivabradine), a drug costing less than £10 a week has been proven to improve survival of patients with heart failure (ref 1,2) according to new research presented at the European Society of Cardiology (ESC) meeting in Stockholm.
Read more on PharmiWeb
